DILANTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dilantin, and what generic alternatives are available?
Dilantin is a drug marketed by Viatris, Parke Davis, and Pharmacia. and is included in four NDAs.
The generic ingredient in DILANTIN is phenytoin. There are twenty-one drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the phenytoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dilantin
A generic version of DILANTIN was approved as phenytoin by TARO on March 8th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DILANTIN?
- What are the global sales for DILANTIN?
- What is Average Wholesale Price for DILANTIN?
Summary for DILANTIN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 155 |
| Clinical Trials: | 23 |
| Patent Applications: | 3,794 |
| Drug Prices: | Drug price information for DILANTIN |
| Drug Sales Revenues: | Drug sales revenues for DILANTIN |
| DailyMed Link: | DILANTIN at DailyMed |
Recent Clinical Trials for DILANTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bristol-Myers Squibb | Phase 1 |
| Lawson Health Research Institute | Phase 4 |
| UCB Pharma GmbH | Phase 4 |
Pharmacology for DILANTIN
US Patents and Regulatory Information for DILANTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viatris | DILANTIN | phenytoin sodium | CAPSULE;ORAL | 084349-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Pharmacia | DILANTIN | phenytoin | TABLET, CHEWABLE;ORAL | 084427-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Viatris | DILANTIN | phenytoin sodium | CAPSULE;ORAL | 084349-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Parke Davis | DILANTIN | phenytoin sodium | INJECTABLE;INJECTION | 010151-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Viatris | DILANTIN-30 | phenytoin | SUSPENSION;ORAL | 008762-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Viatris | DILANTIN-125 | phenytoin | SUSPENSION;ORAL | 008762-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
